Laddar...
PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series
Hypercytokinemia induced by coronavirus disease-19 (COVID-19) is associated with severe pulmonary involvement, which may lead to respiratory failure. These conditions play an important role in the worsening of clinical symptoms in patients with severe COVID-19. There is no established treatment for...
Sparad:
| I publikationen: | Infect Drug Resist |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8040694/ https://ncbi.nlm.nih.gov/pubmed/33854342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S299023 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|